These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 29950206)

  • 1. [Establishment of Drug-resistant Acute Lymphoblastic Leukemic Cell Lines and Their Resistance Mechanism].
    Li TT; Zhang L; Tao SD; Ma JJ; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Jun; 26(3):698-704. PubMed ID: 29950206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Multidrug resistant gene MDR1 contributes to development of imatinib-resistance in Ph (+) acute lymphoblastic leukemia cell line SUP-BS15RI].
    Lin J; Xing HY; Gong YP; Yang X; Guo Y; Shan QQ; Zhou RQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Sep; 43(5):657-60, 665. PubMed ID: 23230732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Establishment of Cytarabine-resistant Acute Lymphoblastic Leukemia Cell Lines and Its Resistance Mechanism].
    Qin X; Liu J; Chen X; Zhong FF; Yang Y; Zeng Y; Li C; Liu WJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Oct; 29(5):1403-1410. PubMed ID: 34627417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of bone marrow stromal cells on the chemotherapeutic sensitivity of acute lymphoblastic leukemia cells].
    Wang Y; Han ZX; Zhang JC
    Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):885-890. PubMed ID: 29262503
    [No Abstract]   [Full Text] [Related]  

  • 5. Targeting P-Glycoprotein: Nelfinavir Reverses Adriamycin Resistance in K562/ADR Cells.
    Liu W; Meng Q; Sun Y; Wang C; Huo X; Liu Z; Sun P; Sun H; Ma X; Liu K
    Cell Physiol Biochem; 2018; 51(4):1616-1631. PubMed ID: 30497065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of multidrug resistant in cancer cells by EGCG, tannic acid and curcumin.
    Li H; Krstin S; Wink M
    Phytomedicine; 2018 Nov; 50():213-222. PubMed ID: 30466981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of newly established adriamycin resistant human leukemic cell lines (KY-ADR1 and KY-ADR2).
    Fukuda T; Kakihara T; Kamishima T; Ohnishi Y; Naito M; Kishi K; Shibata A; Tsuruo T
    Leuk Res; 1994 Sep; 18(9):709-15. PubMed ID: 7934146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of PCI-32765 and Dasatinib on the Acute Lymphoblastic Leukemic Cells and Their Mechanisms].
    Deng Y; Tao SD; Zhang X; Ma JJ; He ZM; Chen Y; Deng ZK; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):72-79. PubMed ID: 28245378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of non-P-glycoprotein mediated high-level etoposide resistant cell lines by adriamycin with P-gp inhibitors.
    Ades S; Maxfield LF; Gould CJ; Jones GK; Levy SB
    Int J Oncol; 2006 Mar; 28(3):747-53. PubMed ID: 16465381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The Roles of Glut5 in Imatinib Resistance in the Ph
    Yan TY; Naren DL; Gong YP
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 May; 48(3):389-393. PubMed ID: 28616912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of newly established human myeloid leukemia cell line (KF-19) and its drug resistant sublines.
    Fukuda T; Kamishima T; Kakihara T; Ohnishi Y; Suzuki T
    Leuk Res; 1996; 20(11-12):931-9. PubMed ID: 9009251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The study of resistant mechanisms and reversal in an imatinib resistant Ph+ acute lymphoblastic leukemia cell line.
    Xing H; Yang X; Liu T; Lin J; Chen X; Gong Y
    Leuk Res; 2012 Apr; 36(4):509-13. PubMed ID: 22285507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reversal of adriamycin resistance by digoxin in human breast cancer cell line MCF-7/adriamycin and its mechanism].
    Li BH; Yuan L; Shi RR; Wang JG
    Sheng Li Xue Bao; 2015 Dec; 67(6):611-7. PubMed ID: 26701637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of VE-cadherin on sensitivity to Imatinib in Sup-B15 Philadelphia chromosome positive acute lymphoblastic leukemia cells].
    Zhang HX; Yan ZL; Song XG; Lü C; Cao J; Li ZY; Zeng LY; Chen C; Xu KL
    Zhonghua Xue Ye Xue Za Zhi; 2013 Jun; 34(6):522-6. PubMed ID: 23827112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal effect of PI3-K inhibitor LY294002 on P-glycoprotein-mediated multidrug resistance of human leukemia cell line K562/DNR and gastric cancer cell line SGC7901/ADR.
    Zhang Y; Qu XJ; Liu YP; Yang XH; Hou KZ; Teng YE; Zhang JD
    Ai Zheng; 2009 Feb; 28(2):97-9. PubMed ID: 19550116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Niemann-Pick disease type C1(NPC1) is involved in resistance against imatinib in the imatinib-resistant Ph+ acute lymphoblastic leukemia cell line SUP-B15/RI.
    Naren D; Wu J; Gong Y; Yan T; Wang K; Xu W; Yang X; Shi F; Shi R
    Leuk Res; 2016 Mar; 42():59-67. PubMed ID: 26818574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.
    Gu J; Fang X; Hao J; Sha X
    Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reversal effect and its mechanism of (- )-5-N-acetylardeemin on adriamycin resistance in multidrug-resistant cancer cells A549/Adr and MCF-7/Adr].
    Zhao C; Zheng XL; Yan YY; Song H; Li DX; Yang L; Qin Y; Lin Y; Wang X; Liao LC
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Nov; 45(6):893-7. PubMed ID: 25571710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
    Li C; Guan X; Xue H; Wang P; Wang M; Gai X
    Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxorubicin-gallium-transferrin conjugate overcomes multidrug resistance: evidence for drug accumulation in the nucleus of drug resistant MCF-7/ADR cells.
    Wang F; Jiang X; Yang DC; Elliott RL; Head JF
    Anticancer Res; 2000; 20(2A):799-808. PubMed ID: 10810357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.